Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May;54(5):2265-8.
doi: 10.1128/AAC.01717-09. Epub 2010 Mar 15.

Antimicrobial susceptibilities of health care-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada, 1995 to 2008

Andrew E Simor  1 , Lisa Louie, Christine Watt, Denise Gravel, Michael R Mulvey, Jennifer Campbell, Allison McGeer, Elizabeth Bryce, Mark Loeb, Anne Matlow; Canadian Nosocomial Infection Surveillance Program
Collaborators, Affiliations

Antimicrobial susceptibilities of health care-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada, 1995 to 2008

Andrew E Simor et al. Antimicrob Agents Chemother. 2010 May.

Abstract

We determined the in vitro antimicrobial susceptibilities of 7,942 methicillin-resistant Staphylococcus aureus (MRSA) isolates obtained from patients hospitalized in 48 Canadian hospitals from 1995 to 2008. Regional variations in susceptibilities were identified. The dissemination of community-associated strains in Canada appears to have contributed to increased susceptibility of MRSA to several non-beta-lactam antimicrobial agents in the past decade. Reduced susceptibility to glycopeptides was not identified.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Adam, H. J., L. Louie, C. Watt, D. Gravel, E. Bryce, M. Loeb, A. Matlow, A. McGeer, M. R. Mulvey, A. E. Simor, and the Canadian Nosocomial Infection Surveillance Program. 2010. Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995 to 2006. Antimicrob. Agents Chemother. 54:945-949. - PMC - PubMed
    1. Christianson, S., G. R. Golding, J. Campbell, the Canadian Nosocomial Infection Surveillance Program, and M. R. Mulvey. 2007. Comparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 45:1904-1911. - PMC - PubMed
    1. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. M100-S19. Clinical Laboratory Standards Institute, Wayne, PA.
    1. Deresinski, S. 2005. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin. Infect. Dis. 40:562-573. - PubMed
    1. Gilbert, M., J. MacDonald, D. Gregson, J. Siushansian, K. Zhang, S. Elsayed, K. Laupland, T. Louie, K. Hope, M. Mulvey, J. Gillespie, D. Nielsen, V. Wheeler, M. Louie, A. Honish, G. Keays, and J. Conly. 2006. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. Can. Med. Assoc. J. 175:149-154. - PMC - PubMed

Publication types

MeSH terms

Substances